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Local protein synthesis in axons supplies
new ribosomal proteins far from the
nucleolus, the known site of ribosome
biogenesis. Shigeoka et al. provide
evidence that axonally synthesized
ribosomal proteins join pre-existing
ribosomes and maintain translation
activity in axons, which is required for
axon terminal branching.
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Ribosome assembly occurs mainly in the nucleolus,
yet recent studies have revealed robust enrichment
and translation of mRNAs encoding many ribosomal
proteins (RPs) in axons, far away from neuronal cell
bodies. Here, we report a physical and functional
interaction between locally synthesized RPs and ri-
bosomes in the axon. We show that axonal RP trans-
lation is regulated through a sequence motif, CUIC,
that forms an RNA-loop structure in the region imme-
diately upstream of the initiation codon. Using imag-
ing and subcellular proteomics techniques, we show
that RPs synthesized in axons join axonal ribosomes
in a nucleolus-independent fashion. Inhibition of
axonal CUIC-regulated RP translation decreases
local translation activity and reduces axon branching
in the developing brain, revealing the physiological
relevance of axonal RP synthesis in vivo. These re-
sults suggest that axonal translation supplies cyto-
plasmic RPs to maintain/modify local ribosomal
function far from the nucleolus in neurons.
INTRODUCTION
RNA localization and local translation play key roles in the as-
sembly, maintenance, and repair of neuronal connections (De-
glincerti and Jaffrey, 2012; Holt and Schuman, 2013; Jung
et al., 2012; Rishal and Fainzilber, 2014; Willis and Twiss,
2006). Recent genome-wide studies on the axonal transcriptomeCell Repo
This is an open access article undreveal that thousands of mRNAs are localized to axons (An-
dreassi et al., 2010; Gumy et al., 2011; Nijssen et al., 2018; Zivraj
et al., 2010). A consistent but unexpected finding of these
studies is the robust enrichment of mRNAs that encode ribo-
somal proteins (RPs) in axons of a variety of neuron types (An-
dreassi et al., 2010; Briese et al., 2016; Cajigas et al., 2012; Gioio
et al., 2004; Gumy et al., 2011; Moccia et al., 2003; Saal et al.,
2014; Taylor et al., 2009; Zivraj et al., 2010). This finding cannot
simply be explained by Brownian diffusion of mRNAs from the
soma, since several studies showed that these transcripts are
significantly enriched in the axon compared to the cell body (An-
dreassi et al., 2010; Saal et al., 2014), suggesting the presence of
mechanisms that selectively target RP-coding transcripts to the
axon. Furthermore, recent studies provide evidence that RP-
coding mRNAs are robustly translated in retinal ganglion cell
(RGC) axons both in vivo (Shigeoka et al., 2016) and in vitro (Cag-
netta et al., 2018), raising the possibility that locally supplied RPs
serve to support axonal function.
Axons are long neuronal processes that carry out many vital
specific cellular functions far from their cell bodies, including
translation, and must therefore maintain their protein synthetic
machinery in good order. However, because eukaryotic ribo-
some assembly is known to occur mainly in the nucleolus (Fro-
mont-Racine et al., 2003; Lastick and McConkey, 1976; Peña
et al., 2017), the physiological function of axonally synthesized
RPs in a neuronal subcellular compartment far distant from the
nucleus is enigmatic. Recent studies on spinal muscular atrophy
(SMA) implicated a potential role for free RPs in the maintenance
of ribosomes in axons (Bernabò et al., 2017; Rage et al., 2013).
The depletion of the survival motor neuron (SMN) protein, an
RNA-binding protein that associates with RP-coding mRNAs
(Rage et al., 2013), caused a significant decrease in translationrts 29, 3605–3619, December 10, 2019 ª 2019 The Authors. 3605
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Figure 1. RP-Coding mRNAs Harbor a Common Loop Structure-Forming Sequence Motif in the 50 UTR
(A) Enrichment of GO terms in the Xenopus laevis RGC axon transcriptome.
(B) Relative abundance (FPKM) of translated mRNAs coding for RPs (red) and other proteins (gray) in the mouse RGC axon (y axis) and retina (x axis), obtained by
the Axon-TRAP system in vivo. The histogram (lower) shows the distribution of the ratio of abundance of 2 consecutive stages (refinement [P7.5]/branching
[P0.5]). p value: Kolmogorov-Smirnov test between RP coding mRNAs and non-RP mRNAs.
(legend continued on next page)
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levels of RP-coding mRNAs (Bernabò et al., 2017). SMN deple-
tion also leads to a 27% reduction in the number of ribosomes
in axons (Bernabò et al., 2017). Although the causal relation re-
mains uncertain, one possibility is that axonally synthesized
RPs are used to make integral components of functional
ribosomes.
The eukaryotic ribosome is a macromolecular machine
composed of 4 ribosomal RNA (rRNA) molecules and 80
different RPs. Eukaryotic RPs are shipped into the nucleus for
assembly into ribosomal subunits within the nucleolus, although
a few ribosomal proteins are added to the ribosome in the cyto-
plasm, such as Rpl24/eL24, Rpl10/uL16, and Rplp0/uL10 (Panse
and Johnson, 2010). A number of previous studies called into
question the widely held view of the ribosome as a stable molec-
ular machine whose components remain unchangeable during
its lifetime. For example, several RPs in the ribosome have higher
turnover rates than other RP components, suggesting the possi-
bility that individual RPs in the ribosome can be replaced by free
cytoplasmic RPs (Lastick and McConkey, 1976; Mathis et al.,
2017; Samir et al., 2018). These studies, together with the robust
axonal translation of RPs, prompted us to ask whether axonal ri-
bosomes incorporate locally synthesized RPs to maintain ribo-
some function far from the cell body.
In this study, we explored roles of axonally synthesized RPs
using a range of technical approaches, including live imaging,
in vivo axon-specific knockdown, and mass spectrometry-
based proteomics. We found that RP translation is regulated
by a branch-promoting factor, Netrin-1, through a loop struc-
ture-forming sequence motif called CUIC, that is shared by
70%of RP-codingmRNAs. Isoforms of RPmRNAswith a short
50 UTR truncated at the CUIC region are highly enriched in axons.
Transcriptome and proteome analyses revealed that the struc-
tural positions of axonally abundant RPs are biased toward the
surface of the ribosome subunits. Live imaging and subcellular
proteomic approaches showed that axonally synthesized RPs
physically associate with axonal ribosomes in a nucleolus-inde-
pendent fashion. Furthermore, we show that inhibition of axonal
RP synthesis leads to a significant decrease in the level of axonal
mRNA translation and severe axon branching defects in vivo.
These results support the view that ribosome function is main-
tained by a cytoplasmic pool of locally synthesized RPs in axons.
RESULTS
RP-Coding mRNAs Harbor a Common Loop Structure-
Forming Sequence Motif in Their 50 UTR
To analyze the axonal transcriptome and proteome, we used a
well-established method to harvest pure RGC axons from em-
bryonic Xenopus eyes grown on microporous transfilters (Fig-(C) Relative position of the CUIC and RNA-secondary structure of 50 UTRs of mous
the predicted secondary structure. The position of CUIC is aligned at center (0 n
(D) Average fraction of double-stranded nucleotides around the CUIC motif in 5
window).
(E) The ranking of RBPs that specifically bind to the CUICmotif of RP-codingmRN
in the upper panel. The histogram (left) shows the average of the specificity sco
ponents, and blue dots mark TIA1 and TIAL1.
(F) UCSC Genome browser view of CLIP clusters of eIF3 components on 2 RP-cure S1A) (Cagnetta et al., 2018; Zheng et al., 2001). The intact
nature of the eyes permits only the axons, not the dendrites, of
RGCs to grow out of the eye (via the optic nerve) onto the trans-
filter with soma-excluding 1mm pores (Figure S1A). The purity of
the axon sample was confirmed by RT-PCR and immunostaining
of soma/nuclear factors (Figure S1B) (Cagnetta et al., 2018). Us-
ing this pure axon material, we first performed an RNA
sequencing (RNA-seq) analysis of RGC axons. Consistent with
previous studies (Deglincerti and Jaffrey, 2012), RPs were
robustly enriched in the axonal transcriptome (Figure 1A). Next,
we investigated a potential physiological role of axonal RP syn-
thesis by analyzing our genome-wide translatome data of mouse
RGC axons in vivo (Shigeoka et al., 2016). The axonal translation
ofmost RP-codingmRNAs peaks during the branching/synapto-
genesis stage (postnatal day [P] 0.5) and declines thereafter in a
synchronous manner (Figure 1B). The pattern of translational
changes of RP-coding mRNAs during the postnatal period
(P0.5–P7.5) was significantly different from the other translated
mRNAs (Figure 1B, lower panel), suggesting the presence of a
mechanism that co-regulates the synthesis of many different
RPs in axons.
The coordinated axonal RP synthesis led us to infer that RP-
coding mRNAs may have a common cis-regulatory element(s).
A de novomotif discovery algorithm (Heinz et al., 2010) revealed
that70%of RP-codingmRNAs share a 50 UTR sequencemotif,
YYYYTTYC (Figure S1C). Since this motif is located immediately
(20–80 nt) upstream of the initiation codon of RP-coding mRNAs
in most cases (>90%) (Figures 1C and S1D), we called this motif
cis-element upstream of the initiation codon (CUIC). Gene
Ontology (GO) enrichment analysis revealed that not only ribo-
some-related GO terms but also those linked to neuron morpho-
genesis are enriched in all CUIC-containing mouse genes (Fig-
ure S1E), suggesting a potential role of the CUIC motif in axon
projection and branching. Consistent with this, translatome anal-
ysis in RGC axons reveals that CUIC-containing transcripts have
significantly higher translation levels than those without (Fig-
ure S1F). The predicted RNA secondary structure of 50 UTRs of
RP-coding mRNAs shows that the nucleotide region around
the CUIC motif tends to form a single-stranded loop, which
may allow trans factors to recognize this motif (Figures 1C and
S1G; Table S1). The sequence and the loop structure are well
conserved among animal species (Figures 1D and S1H).
To explore which RNA-binding proteins (RBPs) associate with
the CUICmotif, we analyzed published cross-linking immunopre-
cipitation (CLIP)-seq datasets in the POSTAR2 database (Zhu
et al., 2019). In this analysis, we counted the number of CLIP clus-
ters that overlapped with the CUIC region of RP-coding mRNAs
for each RBP and normalized them to the total number of clusters
on any region of the mRNAs to evaluate the specificity of RBPe RP-coding mRNAs. Each bar represents 50 UTR sequences and is colored by
t) and the x axis indicates the distance from the CUIC motif.
0 UTRs of all CUIC-containing mouse genes and RPs (moving average, 7-nt
As. The heatmap color indicates the specificity score calculated by the formula
re of each RBP for all CUIC-containing RP mRNAs. Red dots mark eIF3 com-
oding mRNAs.









Figure 2. CUIC Motif Is Involved with Alternative 50 End and Netrin-1-Stimulated Translation of Axonal RP mRNAs
(A) Plot showing the difference of the position of 50 terminal of CUIC-containing mRNAs between the axon and the whole embryo. The x axis indicates the relative
position of 50 terminal compared to CUIC.
(legend continued on next page)
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binding (Figure 1E). This revealed that components of the eIF3
complex are particularly enriched in the proteins that specifically
bind to the CUIC motif of RP-coding mRNAs (Figures 1E and 1F).
CUIC Motif Is Associated with Alternative 50 Ends and
Netrin-1-Stimulated Translation of Axonal mRNAs
Our analysis of CLIP-seq data also showed that TIA1 and TIAL1
bind with high specificity to the CUIC region (Figure 1E). Since
these proteins were reported to be key factors in 50 terminal oli-
gopyrimidine tract (50 TOP) mRNA regulation (Damgaard and
Lykke-Andersen, 2011), we sought to understand the relation
between CUIC and 50 TOP mRNAs. Although both the CUIC
and 50 TOP motif are a tract of pyrimidine nucleotides in the 50
UTR, CUIC is always immediately upstream of the initiation
codon and is usually distant from the 50 end, unlike the 50 TOP
sequence, which is always at the 50 terminal of mRNAs (Meyu-
has, 2000). Several RP-coding mRNAs contain both the 50 TOP
and CUIC motifs in separate positions (Figure S2A). However,
since we found that the mouse expressed sequence tag (EST)
showed that the positions of 50 ends of the CUIC-containing
RP mRNAs are highly variable, an interesting possibility is that
the alternative 50 end formed at the CUIC region generates a 50
TOP-like sequence. To explore this possibility, we analyzed the
50 end sequence of CUIC-containing mRNAs in our Xenopus
RGC axon RNA-seq data. Whereas the 50 ends of CUIC-contain-
ing transcripts detected in Xenopus whole embryos (Ding et al.,
2017) are located upstream (0–300 nt) of the CUIC region in most
cases, the 50 ends of those in the RGC axon sample tended to
have short 50 UTRs that were truncated at the CUIC region (Fig-
ures 2A, 2B, and S2B). This prevalence of short isoforms in axons
was validated by 50 rapid amplification of cDNA ends (RACE)
comparing the 50 end of Rps4x/eS4 transcripts between the
RGC axon and the somal (whole-eye) samples (Figure 2C).
Sequencing of the amplified cDNAs showed that the 50 end of
the Rps4x/eS4 short isoform is precisely located at the CUIC re-
gion (Figure 2C). These results suggest that the alternative 50 end
at the CUIC region can generate a 50 TOP-like sequence in RP-
coding mRNAs (Figure 2B). Since 50 TOP mRNAs are regulated
by the mammalian target of rapamycin (mTOR) pathway (Jeff-
eries et al., 1997), and the mTOR pathway is required for Ne-
trin-1-mediated local translation (Campbell and Holt, 2001), the
CUIC motif could play a crucial role in regulated RP synthesis
in the axon. To investigate the relation between Netrin-1 stimula-
tion and CUIC-containing RPmRNAs, we analyzed a proteomics
dataset of the cue-induced nascent (newly synthesized) prote-
ome in cultured Xenopus RGC axons (Cagnetta et al., 2018).
The analysis revealed that RPs are particularly enriched in the
group of proteins whose translation is promoted by Netrin-1(B) Diagram showing 2 isoforms of the CUIC-containing mRNA with alternative 5
(C) Diagram (left), gel image (middle), and Sanger sequencing result (right) of 50 R
(D and E) Representative images (D) and quantification of quantitative immunoflu
Netrin-1 + CHX) and Rps4x/eS4 (n = 59, control; 50, CHX; 70, Netrin-1; 44, Netrin
(CHX) treatment (bars, average with 95% confidence interval [CI], Mann-Whitney
(F and G) Plots (F) and representative images (G) of relative fluorescence recove
growth cones. ***p < 0.0001; 2-way ANOVA comparing full-length UTRs (n = 8) w
(H) Moving average (20 s window) of the count of detected translation events per u
imaging. p value: Mann-Whitney U test between full-length UTRs (n = 11) and De(p = 0.0001, enrichment of GO: 0005840) (Figure S2C; Tables
S2 and S3). Consistent with this result, quantification of the
immunofluorescence (QIF) signal showed that Netrin-1 in-
creases the translation of most, but not all, RPs tested in axonal
growth cones (Figures 2D, 2E, S2D, and S2E). We next investi-
gated the effect of the CUICmotif on axonal RP synthesis by per-
forming fluorescence recovery after photobleaching (FRAP)
experiments using the fast-folding fluorescent protein Venus, ex-
pressed from mRNAs with and without the CUIC motif in the
UTR. We tested the UTR of Rps4x/eS4, the RP that shows the
greatest increase in axonal translation after Netrin-1 stimulation
(Figures 2D, 2E, and S2C). While no significant difference was
observed in the FRAP signal in basal conditions over the
10-min period of imaging, the addition of Netrin-1 elicited a
significantly higher FRAP signal with the full-length 50 UTR re-
porter compared to the CUIC-deleted or 50 UTR-deleted reporter
constructs (Figures 2F and 2G), indicating a higher translation
rate of the CUIC-containing mRNA. The inhibition of translation
with anisomycin abolished this difference (Figure S2F). Consis-
tent with these FRAP results, independent experiments using a
single-molecule translational imaging approach (Ifrim et al.,
2015; Ströhl et al., 2017; Tatavarty et al., 2012) that captures in-
dividual translation events in real-time revealed a significantly
higher number of translation events with the CUIC-containing
reporter, compared to the CUIC-deleted reporter, in Netrin-1-
stimulated axonal growth cones (Figure 2H). These data provide
evidence that the CUIC motif is, at least partially, responsible for
the Netrin-1-induced axonal translation of RPs.
Surface Components of the Ribosomal Subunits Are
Enriched in the Axoplasm
The coordinated regulation of numerous axonally synthesized
RPs suggests that they may have a common ribosome-related
function rather than a disparate variety of extra-ribosomal roles
(Warner and McIntosh, 2009) in axons. However, since most ri-
bosomal proteins are thought to be assembled into ribosomes
exclusively in the nucleolus, it seemed puzzling that ribosomal
proteins are synthesized in the distal axon, far away from the
nucleolus (Fromont-Racine et al., 2003). To test the possibility
that the retrograde transport of axonally synthesized RPs allows
their assembly into ribosomes in the nucleolus, we focused on
the abundance of RPs outside of ribosomes (free cytoplasmic
RPs) in the distal axon. Robust axonal RP translation should
result in the accumulation of free RPs in the axon, unless these
are retrogradely transported toward the soma or quickly
degraded. To detect free RPs in the axon, we performed sucrose
density gradient fractionation on pure-axon lysates, generated
using Boyden chambers, as well as on whole-brain lysates0 ends and the 50 TOP mRNA.
ACE products of Rps4x/eS4 mRNAs in axon and eye samples.
orescence (QIF) (E) for Rps14/uS11 (n = 42, control; 59, CHX; 66, Netrin-1; 64,
-1 + CHX) in RGC growth cones with or without Netrin-1 (5 min)/cycloheximide
U test compared to the control, ***p % 0.001, *p % 0.05). Scale bar, 5 mm.
ry of Venus reporter constructs after photobleaching (error bar, SEM) in RGC
ith Del-motif (n = 12). Scale bar, 2 mm.
nit area per second with the Netrin-1 stimulation in single-molecule translation
l-motif (n = 12) using the total count in each growth cone.
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A
B
C Figure 3. Structural Positions of RPs En-
coded by Axonally Localized mRNAs Are
Surface Biased
(A) Formula of interface-index (upper) and a partial
structure of the ribosome, generated with PyMOL,
showing the relation between RP position and
interface-indices.
(B) Human 80S ribosome structure, generated
with PyMOL, showing the position of all RPs that
are classified based on the interface-index.
(C) Ranking of abundance (average FPKM) of RPs
coding mRNAs (n = 2) and interface-index scores
of RPs (more blue = higher, more red = lower).(Figures S3A–S3C). Mass spectrometry analysis of the fraction-
ated samples showed a robust accumulation of free RPs in ribo-
some-free fractions of the axon lysate, whereas RPs were
strongly depleted in ribosome-free fractions of the whole-brain
lysate (Figure S3D), suggesting that axonally translated RPs
have function(s) in the axon rather than in the nucleolus.
To evaluate whether axonally translated RPs are involved in ri-
bosomal function, we focused on the position of these RPs in the
ribosome structure. We reasoned that if the axonally translated
RPs are used to replace/repair components of the ribosome,
the position of these RPs may be biased to the surface of the
ribosome because RPs that penetrate deeply into the rRNA
core of ribosomal subunits are less likely to be replaced or de-
tached. To address this, we performed an unbiased classifica-
tion of RPs (surface or core/penetrated) based on their structural
position in the human 80S ribosome structure (Natchiar et al.,
2017). For each RP, we assigned an interface-index score based
on the fraction of residues that interface with rRNA by using
the PyMOL function InterfaceResidues (https://pymolwiki.org/
index.php/Main_Page). RPs with a high interface-index score
(high fraction of rRNA interface residues) tend to be located
deep in the ribosome core or have long tails that penetrate into3610 Cell Reports 29, 3605–3619, December 10, 2019the core (Figures 3A and 3B). We found
that the group of RPs whose mRNAs are
abundant in the axon (FPKM > 100,
61 RPs) had a significantly lower inter-
face-index average (0.42) than the less
abundant (FPKM < 100) group (0.57, Kol-
mogorov-Smirnov test, p = 0.014) (Fig-
ure 3C). Consistently, RPs with high
interface-indices (>0.6; Figure 3B) were
significantly depleted from the abundant
group (5.0-fold depletion, Fisher’s exact
test, p = 0.0016) (Figure 3C). Although
label-free quantification (LFQ) of mass
spectrometry is a less robust quantitative
method compared to RNA-seq, we
observed a similar trend in which high
interface-indices (>0.6) were significantly
depleted from the group of RPs with high
abundance (LFQ abundance score > 1) in
the axonal ribosome-free fraction (Fig-
ure S3E). These results indicate that the
axon, but not the cell body, contains alarge cytoplasmic pool of extra-ribosomal RPs that are biased
to occupy superficial structural positions in the ribosome and
suggest the possibility that surface components of axonal ribo-
somes may be replaced by these cytoplasmic free RPs in axons.
Axonally Synthesized RPs Become Physically
Associated with Ribosomes
To investigate the interaction of axonally synthesized RPs with
the ribosome, we first performed an in situ proximity ligation
assay (PLA), a technology capable of detecting the close phys-
ical association between 2 molecules (<400 Å) (Yoon et al.,
2012). We carried out metabolic labeling of newly synthesized
proteins with L-azidohomoalanine (AHA) in severed axons (Diet-
erich et al., 2007). After biotin conjugation to AHA via ‘‘click’’
chemistry, we performed PLA to detect the association between
axonally synthesized proteins (biotin antibody) and ribosomes,
using the anti-rRNA antibody Y10B (Aakalu et al., 2001) (Fig-
ure 4A). As eukaryotic ribosomes are 250–300 Å in diameter,
the proximity between the AHA-labeled RPs and the rRNA is ex-
pected to generate a PLA signal if axonally synthesized RPs are
incorporated into axonal ribosomes (Figure 4A). To eliminate





Figure 4. Axonally Synthesized RPs Co-
localize with Ribosome-Containing Gran-
ules
(A) Experimental workflow and a diagram
describing the positional relation of each protein/
probe in the rRNA-FUNCAT-PLA experiments.
(B and C) Representative images (B) and plots for
the number of PLA puncta in each condition (C)
detected in the axon (bars, average with 95% CI,
Mann-Whitney U test, ***p % 0.001). Scale bar,
5 mm.
(D) Experimental workflow of the Venus + Cy5-
UTP FRAP experiments (upper). Live imaging of
Cy5-UTP (magenta) and UTR-Rps4x-Venus fusion
or UTR-Venus (green) reporter before and 0, 5, and
10 min after photobleaching of the Venus (green)
fluorescence. The yellow arrowheads indicate the
sites of co-localization, and thewhite lines indicate
the outlines of axons. Scale bar, 2 mm.
(E) Plot showing Pearson’s correlation coefficient
of pixel intensities between Cy5-UTP signals and
recovered Venus signals (Venus-Rps4x [n = 8] or
Venus-only [n = 12]). Bars, average with SEM,
Mann-Whitney U test, *p % 0.05.chains, axons were treated with 200 mM puromycin, which re-
leases growing polypeptide chains from the ribosome (Cioni
et al., 2019; Nathans, 1964) before the sample fixation. We
observed a clear PLA signal in the axons, which was abolished
by anisomycin treatment (Figures 4B and 4C). We also found
that the PLA signal was significantly higher in Netrin-1-stimu-
lated axons than in unstimulated axons (Figures 4B and 4C),
which is consistent with the results that Netrin-1 promotes
axonal RP synthesis (Figures 2 and S2). While these proximity-
based results do not rule out the association of newly synthe-
sized non-RP factors with the surface of axonal ribosomes,
they demonstrate that some proteins synthesized in response
toNetrin-1 in axons become closely associated on-site with ribo-
somes and support the idea that newly synthesized RPs join
axonal ribosomes.
To look specifically at the question of whether newly synthe-
sized RPs themselves co-localize with ribosomes, we used aCell Reportsmodified FRAP approach and dual-chan-
nel time-lapse imaging in live axons. We
have previously shown that blastomere-
injected labeled UTP is incorporated pre-
dominantly into ribosomal RNAs (Wong
et al., 2017) and that translation takes
place on these Cy5-UTP granules in live
retinal axons (Wong et al., 2017; Cioni
et al., 2019). Therefore, we used Cy5-
UTP as a live reporter of ribosome/RNA-
rich granules. We also introduced a
cDNA encoding Venus-Rps4x/eS4, an
RP fusionprotein.Weobserved thatbright
fluorescent puncta of Venus-Rps4x/eS4,
but not theVenus-only control, co-localize
and co-move with Cy5 fluorescent
puncta, confirming that Cy5-UTP labelsribosome/RNA-rich granules (Figures 4D and S4). Next, to visu-
alize the newly synthesized Venus proteins, we performed photo-
bleaching of the Venus fluorescence with 488-nm laser light and
then examined the co-localization between Cy5-UTP fluores-
cence and the recovered Venus signal. Before photobleaching,
we cut the axons to exclude the signal of Venus proteins trans-
ported from the soma. Immediately post-cut and before photo-
bleaching,weaddedNetrin-1 to stimulate axonalRps4x/eS4syn-
thesis. Time-lapse imaging revealed that the signal of recovered
(axonally synthesized) Venus-Rps4x/eS4 protein, but not of con-
trol Venus protein, exhibited sustained co-localization with Cy5-
labeled RNA after photobleaching in severed somaless RGC
axons (Figures 4D and S4). This result was further confirmed by
a spatial correlation analysis, in which the correlation (Pearson’s
correlation coefficient) of the pixel intensities between recovered
Venus-Rps4x and Cy5-UTP signals was significantly higher than







Figure 5. Axonally Synthesized RPs Physi-
cally Interact with the Ribosome in a Nucle-
olus-Independent Manner
(A) Experimental strategy of axon purification,
SILAC labeling, and axonal ribosome purification.
(B) Diagram and gel image of RT-PCR detection of
mature 18S rRNA and pre-rRNA.
(C) Cumulative percentage of the relative position
of labeled peptides detected in axonal (cyan) and
eye (red) ribosome samples.
(D) List of RPs whose labeled peptides were de-
tected in the axonal ribosomes. The heatmap
shows the translation levels of RPs in 3 different
developmental stages of in vivo mouse RGC
axons.
(E) Human 80S ribosome structure with indication
of the RPs whose labeled peptides were detected
in the axonal ribosomes. The colors of the squares
represent the interface-index of each labeled RP
(see Figure 3).
(F) Immunostaining of ribosomal assembly factors
and a secondary antibody-only control in cultured
Xenopus laevis RGC axons. Scale bar, 5 mm.To obtain biochemical evidence for the axonal incorporation of
axonally synthesized RPs into axonal ribosomes, we combined
axon-pSILAC (Cagnetta et al., 2018) with axonal ribosome puri-
fication (Figure 5A). In thismethod, we labeled newly synthesized
proteins with heavy amino acids for 3 h in somaless axons
cultured in a Boyden chamber. Together with heavy amino acids,
Netrin-1 was added to stimulate the axonal translation of RPs.
After the lysis of labeled axons, axonal ribosomes were purified
using a sucrose cushion and ultracentrifugation, followed by the
identification of newly synthesized proteins withmass spectrom-
etry (Figure 5A). To obtain sufficient axonal material,2,000 eyes
were cultured for each sample. Mature 18S rRNA was detected
in both somas and axons, whereas the pre-rRNA, which is pre-
sent only in the nucleolus, was detected only in somata (Fig-
ure 5B), confirming that there was no contamination of the
axon samples with somata/nuclei in these experiments. We
used the same method as a control sample on isolated eyes3612 Cell Reports 29, 3605–3619, December 10, 2019that were treated with heavy amino acids
for 48 h. Mass spectrometry analysis re-
vealed that93% of all detected proteins
in the axonal ribosome samples were in a
single gene-network cluster that includes
RPs and ribosome-interacting proteins,
validating the ribosome purification pro-
cedure (Figure S5A). Mass spectrometry
detected a number of labeled (i.e., axo-
nally synthesized) RP peptides in the
axonal ribosome samples. The ratios of
labeled/unlabeled RP peptides in the
axonal ribosome samples were highly
variable among RPs, whereas relatively
constant ratios of labeled RPs were
observed in whole cells (the eye sample)
(Figure S5B). These results not only
show that locally synthesized RPs physi-cally associate with ribosomes in the axon but they also exclude
the possibility that the detection of labeled RPs in the axonal
ribosome samples is caused by contamination of our axon sam-
ple with cell bodies. We still detected labeled RP peptides in
axons even when the axon lysate was treated with RNase A/T1
and puromycin, which dissociate mRNA-binding proteins,
including the poly(A)-binding protein from the purified ribosomes
(Figures S5C–S5F). This result suggests that the detection of
these labeled RP peptides was not due to the binding of free
extra-ribosomal RPs to the ribosome-bound mRNAs. The puro-
mycin step also ensured that we were not detecting growing
polypeptide chains, which is consistent with the fact that
the position of heavy labeled RP peptides was not biased
toward the N terminus (Figure 5C). Analysis of our mouse in vivo
axonal translatome showed that most (85%) of the labeled RPs
detected in the axonal ribosome samples are axonally synthe-






Figure 6. Locally Synthesized Rps4x/eS4 Is
Required to Maintain Ribosome Function in
Axons
(A) Diagram (left) and image of RGC axons after
FITC-morpholino introduction in a microfluidic
chamber.
(B–F) Images (B, D, and E) and QIF plots (bars,
average, 95% CI, and distribution of normalized
levels) (C and F) of Rps3a/eS1, Rps4x/eS4, Rpl17/
uL22, and puromycin immunostaining in axons
treated with control morpholinos (Cont.) or with
morpholinos against rps3a (eS1) (B and C) or
against rps4x (eS4) (D–F), with Welch t test
(*p = 0.030, C; 0.015, F; ***p = 0.0004; n.s., not
significant).
(G) qRT-PCR quantification, normalized to control
MO, of 18S rRNA in axonal samples treated with
control or rps4x (eS4) morpholinos (n.s., not sig-
nificant in Mann-Whitney U test).(Figure 5D). Most (91%) of these are not deeply penetrated RPs
(Figure 3B) in the ribosome structure (2.2-fold depletion of inter-
face-index < 0.6) (Figures 5D and 5E). Although the subcellular
nature of our material prohibited the use of approaches to
resolve whether the axonally synthesized RPs are actually
embedded in the ribosome in their normal positions, these re-
sults support the idea that locally synthesized RPs physically
associate with axonal ribosomes in a nucleolus-independent
manner.
To explore the possibility that nucleolar ribosome assembly
factors mediate the axonal interaction between RPs and ribo-
somes (Kressler et al., 2010), we searched our Xenopus RGC
axon proteome data (Cagnetta et al., 2018) for proteins whose
mouse ortholog genes were annotated with the GO termsCell Reports‘‘nucleolus’’ (GO: 0005730) or ‘‘ribosome
assembly’’ (GO: 0042255). We found
that 12.6% (124 of 982) of proteins with
these GO terms were detected in our
axon sample, some of which were
confirmed by immunostaining (Figure 5F).
Many of these factors were detected in
the axons of different types of neurons,
such asmouse callosal axons (Poulopou-
los et al., 2019) and axons of rat cortical
neurons (Chuang et al., 2018), suggesting
that the functions of these factors are
conserved among these neuron types
(Figure S5G).
Locally Synthesized Rps4x/eS4 Is
Required to Maintain Ribosome
Function in Axons
Next, we focused on the functional inter-
action between axonally synthesized RPs
and axonal ribosomes. To ask whether
local RP synthesis affects the protein
synthesis activity of axonal ribosomes,
we performed axon-specific inhibition ofRP synthesis using a microfluidic chamber that isolates the
axonal compartment from the cell body compartment (Taylor
et al., 2005). Taking advantage of the fluidic isolation of the
chamber (Taylor et al., 2005), we delivered a FITC-conjugated
morpholino only into the axonal compartment to inhibit axonal
RP synthesis (Figure 6A) for three RPs—Rps3a/eS1, Rps4x/
eS4, and Rpl5/uL18—all of which are synthesized/translated
robustly in RGC axons (Cagnetta et al., 2018; Shigeoka et al.,
2016). Although we could not find a significant effect on axonal
protein synthesis after rps3a (eS1) or rpl5 (uL18) morpholino de-
livery, we found that the rps4x (eS4) morpholino significantly
reduced the level of proteins labeled with puromycin, a structural
analog of aminoacylated-tRNA which labels newly synthesized
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growth cones (Figures 6B–6D, 6F, S6C, and S6D). The rps4x
morpholino decreases the Rps4x/eS4 protein level only in the
axons but not in the somata (Figures 6D, 6F, Figures S6A and
S6B). In addition, we found that neither the level of Rpl17/uL22
nor the level of 18S rRNA was changed by the rps4xmorpholino
(Figures 6E–6G), suggesting that the decreased level of newly
synthesized proteins in axons is not caused by a reduced num-
ber of axonal ribosomes. These data show that the inhibition of
axonal rps4x/eS4 translation decreases the level of translation
activity in the axon, suggesting a crucial role for axonally synthe-
sized Rps4x/eS4 in axonal ribosome function.
Axonal Synthesis of Rps4x/eS4 Is Crucial for Axon
Branching In Vivo
Next, we asked whether newly synthesized RPs incorporated
into axonal ribosomes are critical for axon development in vivo.
Our analysis showed that the axonal synthesis of RPs is
enhanced by Netrin-1, which promotes axon branching (Dent
et al., 2004; Manitt et al., 2009), and it peaks at the branching
stage in mouse RGC axons in vivo (Figure 1B). A previous study
demonstrated that exposed intact brains treated acutely with
protein synthesis inhibitors show a reduction in axonal branch-
ing dynamics in the optic tectum (Wong et al., 2017). Thus, our
finding that Rps4x/eS4 knockdown inhibits axonal protein syn-
thesis (Figure 6) prompted us to test whether the local synthe-
sis of Rps4x/eS4 is essential for the normal branching of axons.
Taking advantage of an in vivo system to visualize single Xen-
opus RGC axons (Wong and Holt, 2018; Wong et al., 2017),
we inhibited Rps4x/eS4 synthesis by morpholino-based knock-
down (Figure 7A). In vivo electroporation of rps4x morpholino
into stage 28 eyes significantly reduced the number, length,
and complexity of RGC axon branches in the optic tectum at
stage 45 (Figures 7A–7D and S7A–S7C). These branching phe-
notypes were rescued by a morpholino-resistant rps4x cDNA
with full-length UTRs, but not by an rps4x cDNA lacking either
the entire 50 UTR or the CUIC motif, suggesting that the CUIC-
mediated regulation of Rps4x/eS4 synthesis is crucial for axon
branching (Figures 7B–7D and S7A–S7C). We next investigated
the role of Rps4x/eS4 synthesis in the dynamics of axon
branching. We first performed in vivo live imaging of axons after
morpholino electroporation into the eye at stage 28 (Wong
et al., 2017). In control embryos at stages 41–43, we observed
a significant bias in the addition over the removal of filopodia
and branches, in agreement with previous work showing that
this bias helps to build arbor complexity (Wong et al., 2017). In-Figure 7. Axonal Translation of Rps4x/eS4 Is Crucial for Axon Branchi
(A) Experimental workflow (upper) for eye electroporation and live image acquisit
conditions.
(B) Lateral view of a single in vivo RGC axon in the tectum with color-coded ima
branches.
(C and D) Average, 95% CI, and distribution of total branch length per axon (C) a
electroporated with the morpholino/rescue constructs (1-way ANOVA with 2-sta
test); n = 21 (Cont. MO), 47 (MO), 21 (MO + WT), 25 (MO + del-50 UTR), and 37 (
(E–G) Experimental workflow for each knockdown (KD) experiment (left) and quan
after eye electroporation (whole-cell KD) (n = 12, Cont.; 20, Rps4x) (E) and tectum
(F), and at stages 35–38 (tectum KD) (lower, n = 10, Cont.; 15, Rps4x) (G). Images
red, and green, respectively). Line graphs (right) show the number of added/remo
not significant).hibition of Rps4x/eS4 synthesis in RGCs abolished this bias. In
addition, the numbers of filopodia and branches being added
and removed were both reduced after rps4x knockdown (Fig-
ures 7E and S7D).
To test whether these phenotypes were caused by the inhibi-
tion of local axonal rather than somal translation of rps4x, we
delivered the rps4x morpholino directly into arborizing RGC
axons in the tectum by electroporation at stages 41–43 (Fig-
ure 7F) (Yoon et al., 2012). To eliminate the possibility that the
intracellular diffusion of the morpholino affects somal ribosome
biogenesis and the number of ribosomes in the RGC axon, we
physically removed the eye, which contains the RGC cell bodies,
before morpholino delivery (Figure 7F) (Wong et al., 2017).
Similar to the global inhibition of rps4x translation in RGCs, local
inhibition of axonal rps4x translation abolished the addition/
removal bias and reduced the number in both filopodia and
branches (Figures 7F and S7E). To evaluate the extent of sec-
ondary effects due to morpholino-electroporated tectal cells,
we delivered the morpholino locally into the tectum before the
arrival of RGC axons (stages 35/36–37/38) and subsequently
visualized the branching dynamics of axons after tectal entry at
stages 41–43. No significant differences were observed in
branching dynamics, indicating that the inhibition of Rps4x/
eS4 synthesis in tectal cells is not responsible for the observed
branching defects in RGC axons (Figures 7G and S7F). These re-
sults indicate that the CUIC-mediated axonal synthesis of
Rps4x/eS4 is critical for the proper arbor development of RGC
axons in vivo (Figure S7G).
DISCUSSION
Our results provide multiple independent lines of evidence
that are consistent with the hypothesis that locally synthesized
RPs in RGC axons are incorporated into axonal ribosomes
and are required to maintain axonal ribosome function and
normal neuronal developmental processes. Since the distal
regions of axons are far away from their somata, our findings
suggest the possibility that they have adopted a nucleolus-in-
dependent mechanism for the on-site repair and/or modifica-
tion of their ribosomes through the local supply of newly
synthesized RPs. Since we could not detect 18S pre-rRNA in
axons (Figure 5B), it is unlikely that de novo assembly of ribo-
somes takes place in axons. A more plausible hypothesis is
that free, extra-ribosomal RPs in axons are incorporated into
pre-existing ribosomes in the axon through the replacementng In Vivo
ion of axon branches/arbors. Dual promoter constructs (lower) used for rescue
ges of axon shaft (white), primary (red), secondary (blue), and tertiary (yellow)
nd axon complexity index (ACI; see Figure S7B for formula) (D) in the embryos
ge step-up method of Benjamini, Krieger, and Yekutiei multiple comparisons
MO + del-CUIC).
tification (right) of in vivo axon branching in control MO and rps4x MO+ axons
electroporation at stages 41–43 (axonal KD) (middle, n = 14, Cont.; 19, Rps4x)
(middle panel) show a merged overlay of 3 time points (0, 5, and 10 min in blue,
ved branches/filopodia (paired and unpaired t test, **p < 0.01, ***p < 0.001; n.s.,
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or addition of components. This model is consistent with recent
proteomics and cryoelectron microscopy studies, which
showed the presence of ribosomes lacking specific RP compo-
nents in eukaryotic cells (Shi et al., 2017; Slavov et al., 2015;
Samir et al., 2018). It seems possible that axonal RP synthesis
plays an important role in ribosome maintenance, particularly
for the surface ribosomal components that may be prone
to damage (Figures 3 and S3). It is also possible, however,
that it modifies the ribosomal composition to generate
‘‘specialized’’ ribosomes (Genuth and Barna, 2018; Kondra-
shov et al., 2011; Shi et al., 2017; Xue et al., 2015), which are
tuned to preferentially translate specific mRNAs that regulate
axon function.
We found that free extra-ribosomal RPs are enriched in axons
compared to the whole cell (Figure S3). This may partly explain
the much higher frequencies of the ribosomal incorporation of
newly synthesized RPs in Netrin-1-stimulated axons (Fig-
ure S5B) than those predicted from previous turnover studies
performed on whole cells (Dice and Schimke, 1972; Lastick
and McConkey, 1976). As Netrin-1-induced axonal RP synthe-
sis may significantly increase the concentration of free RPs in
axons, it may also elicit a transient increase in ribosome incor-
poration of newly synthesized RPs in axons (Figure 5). An impor-
tant question related to this is whether the ribosomal incorpora-
tion of RPs in axons needs any catalytic activity of trans-acting
auxiliary factors. In prokaryotes, a factor-free in vitro assembly
of functional ribosomal subunits has been successfully demon-
strated by bringing together purified rRNAs and RPs (Pulk et al.,
2010; Sykes and Williamson, 2009), but this has not yet been re-
ported in eukaryotes. Accumulating evidence suggests that a
large number of non-ribosomal factors (>200) and small nucle-
olar RNAs are involved in the de novo ribosome assembly in
eukaryotic cells, but most of these factors are related to rRNA
processing or transport of RPs/pre-ribosomes, while only a
few factors have been demonstrated to support the incorpora-
tion of RPs (Kressler et al., 2010). We found that surface compo-
nents of the ribosomal subunits are enriched in the axons. The
binding of RPs to the surface of the ribosome may therefore
be a simpler and different process compared to de novo ribo-
some biogenesis, which comprises the processing and folding
of the pre-rRNA and its sequential assembly with deeply
embedded ribosomal proteins. It is also possible that some
ribosome assembly factors have roles in the axonal incorpora-
tion of some RPs. We detected a considerable number of ribo-
some assembly factors in the axon, although we have not
identified any axonal function for these factors. To fully under-
stand the mechanisms underlying axonal RP incorporation,
further work on the axonally detected ribosome assembly fac-
tors is needed.
We identified a motif called CUIC, which is a form of pyrim-
idine-rich element (PRE) in the region immediately upstream of
the initiation codon of many axonally translated RP mRNAs. It is
known that the 50 TOP sequence plays an important role in the
translational control of mRNAs, including RP-coding mRNAs,
downstream of the mTOR signaling pathway (Levy et al.,
1991). We showed that alternative short isoforms of RP-coding
transcripts truncated at the CUIC region are highly enriched in
the axon, suggesting the possibility that CUIC can function as a3616 Cell Reports 29, 3605–3619, December 10, 201950 TOP-like sequence for these short isoforms in axons. This
finding may provide an integrated explanation for functions of
the 50 TOP motif and other previously reported pyrimidine-
rich sequences, such as the pyrimidine-rich translational
element (PRTE) (Hsieh et al., 2012). Our analysis using previous
CLIP-seq studies revealed that, in addition to the eIF3 com-
ponents, TIA1 and TIAL1, proteins involved with N6-
methyladenosine (m6A) methylation (RBM15 and RBM15B)
and the recognition of m6A (YTHDF1, YTHDF2, and YTHDC1)
(Patil et al., 2016) are specifically associated with the CUIC
region (Figure 1E). Since a recent study reported that an m6A
in the 50 UTR directly binds eIF3, which is sufficient to
recruit the 43S complex to initiate translation in a cap-indepen-
dent manner (Meyer et al., 2015), RNA methylation at
regions surrounding the CUIC motif core sequence and the
subsequent recruitment of the eIF3-43S complex may be
involved in the CUIC-mediated axonal translation. Since CUIC
is located immediately upstream of the initiation codon, one
interesting possibility is that CUIC changes the distance be-
tween the 50 end and the initiation codon through alternative
50 end formation, affecting the positional relation among initia-
tion factors and ribosomes on the mRNA, which in turn may
affect the speed or reliability of translation in response to a
signal.
In this study, we uncovered crucial functions of locally syn-
thesized Rps4x/eS4 in axonal mRNA translation and in proper
axon branching in vivo. Although we cannot exclude the possi-
bility that some unknown extra-ribosomal function of Rps4x/
eS4 is responsible for the axon branching phenotype, we pro-
pose that the intra-ribosomal function of Rps4x/eS4 is more
likely to explain the phenotype observed after axonal inhibition
of Rps4x/eS4 synthesis, since several lines of evidence suggest
that the process of axon branching is highly dependent on local
translation. A previous study showed that RNA granules dock at
sites of branch emergence and invade stabilized branches and
that acute inhibition of axonal translation by protein synthesis
inhibitors and downregulation of the eIF2a pathway cause a
very similar axon branching defect as observed after Rps4x/
eS4 knockdown (Cagnetta et al., 2019; Wong et al., 2017).
Furthermore, our previous analysis of the developmental
changes of the axonal translatome (Shigeoka et al., 2016)
showed that the number of axonally translated mRNAs is high-
est during branching stages, when synapses are being formed.
A recent proteomic study showed that Rps4x/eS4 is the most
significantly sub-stoichiometric among all of the RPs in polyso-
mal ribosomes of eukaryotic cells (Slavov et al., 2015), suggest-
ing an interesting possibility that, compared to Rps4x/eS4-
containing ribosomes, Rps4x/eS4-deficient ribosomes have
less translation elongation activity, which may cause a polyso-
mal ‘‘traffic jam’’ on the mRNA (Chu et al., 2014). These results
suggest the possibility that axonal RP translation induced by
Netrin-1 and the CUIC motif may make axonal ribosomes
competent for the extensive protein synthesis needed for
axon arborization and synaptogenesis (Figure S7G). Collec-
tively, our findings suggest that ribosomes may be dynamic
structures in axons, exchanging/repairing components in
response to extrinsic signals. Further studies are needed to pro-
vide a fuller understanding of how RP mRNA translation in
axons contributes to fundamental processes that establish and/
or maintain neural circuits.STAR+METHODS
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TopHat2 v.2.0.12 RRID: SCR_013035
Cufflinks v.2.2.1 RRID: SCR_014597
HISAT2 v.2.1.0 RRID: SCR_015530
HOMER v.3.0 RRID: SCR_010881
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MATLAB Mathworks; v. R2016b RRID:SCR_001622
GraphPad PRISM Graphpad; v.5 RRID:SCR_002798
MaxQuant v.1.4.1.2 RRID: SCR_014485
RapidSTORM Wolter et al., 2012 N/A
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Other
RNA-seq dataset Shigeoka et al., 2016 GEO: GSE79352
RNA-seq dataset Ding et al., 2017 GEO: GSM1948717
Proteome dataset Cagnetta et al., 2018 PRIDE: PXD005469
POSTAR2 database Zhu et al., 2019 N/A
Microfluidic chambers Xona Microfluidics Cat#SOC150
Falcon Cell Culture Inserts Thermo Fisher Scientific Cat#08-771-7/353102LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and request for resources and reagents should be directed to the Lead Contact, Christine E. Holt (ceh33@cam.
ac.uk). All unique plasmids are available from the Lead Contact.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Xenopus laevis Embryos
Xenopus laevis eggs were fertilized in vitro and embryos were raised in 0.1x Modified Barth’s Saline (MBS; 8.8mMNaCl, 0.1 mMKCl,
0.24mM NaHCO3, 0.1 mM HEPES, 82mM MgSO4, 33mM Ca(NO3)2, 41mM CaCl2) at 14-20
C and staged according to the tables of
Nieuwkoop and Faber (1994). All animal experiments were approved by the University of Cambridge Ethical Review Committee in
compliance with the University of Cambridge Animal Welfare Policy. This research has been regulated under the Animals (Scientific
Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and
Ethical Review Body (AWERB).e3 Cell Reports 29, 3605–3619.e1–e10, December 10, 2019
Primary Xenopus Retinal Cultures
Eye primordia were dissected from Tricaine Methanesulfonate (MS222) (Sigma-Aldrich) anesthetized embryos of either sex at stage
35/36 and cultured on 10mg/ml poly-L-lysine (Sigma-Aldrich)- and 10mg/ml laminin (Sigma-Aldrich)-coated glass bottom dishes
(MatTek) in 60% L-15 medium (ThermoFisher), 1x Antibiotic-Antimycotic (ThermoFisher) at 20C for 24-48 hours. 10-20 eye
primordia (from 5-10 embryos) were cultured per dish and, typically, 2-3 dishes were used per experimental condition for each bio-
logical replicate. Replicates in each experiment using Xenopus laevis in this study were obtained from different batches of embryos.
METHOD DETAILS
RNA-seq analysis of Xenopus laevis axons
Weperformed the axon cultures using eyes of stage 33/34-37/38 embryos of Xenopus laevis (Nieuwkoop and Faber, 1994) on a Boy-
den chamber device as described above at room temperature for 48hrs. To obtain the axonal transcriptome, we isolated total RNA
from RGC axons separated from their cell bodies by a Boyden chamber device (1 mm pore, Falcon Cell Culture Inserts, 10289270/
353102, Thermo fisher scientific) coated on both sides of the membrane with poly-L-lysine (10 mg/ml) and only on the bottom side
with laminin (10 mg/ml). We cultured 500 eyes of Xenopus laevis embryos (stage 33/34-37/38) for each sample, yielding < 4-5mg
axonal material. Eyes were dissected out and cultured as whole eyes on the upper surface of the transfilter in 60% L15 medium con-
taining penicillin streptomycin fungizone (GIBCO) at room temperature for 48 hours. After 48 hours, we removed the cell bodies and
lysed the axons in RLT buffer (QIAGEN) containing b-mercaptoethanol. RNA was then extracted using the RNeasy Mini kit (QIAGEN)
followed by in-column DNase I treatment to remove genomic DNA contamination. We then amplified cDNA using a method devel-
oped for single cell transcriptomics (Tang et al., 2009) with minor modifications (Shigeoka et al., 2016). The cDNA library preparation
was performed using a KAPA Hyperprep kit (Roche) and cDNA libraries were subjected to a RNA-sequencing run on Next-seq 500
instrument (Illumina) using the 150 cycles high output kit (Illumina). The sequence reads were mapped using HISAT 2 version 2.1.0,
and FPKM values were estimated using Cufflinks version 2.1.1. If RP-coding mRNAs are transcribed from two homeologs, we calcu-
lated the average FPKM of homeologs. We used previously published RNA-seq data (GSM1948717) of Xenopus laevis whole em-
bryos for a control.
Plasmid Construction
To construct Venus reporter plasmids used in FRAP and single molecule translation imaging, Venus cDNA and 50 / 30 UTR of mouse
Rps4x/eS4 (NM_009094) were integrated into BamHI-XbaI sites of pCS2+ (University of Michigan, Ann Arbor, Mich.). 8 nucleotides
(CTCTTTCC) in the 50 UTRwere deleted in the ‘‘Del-motif’’ construct. To generate Rps4x-Venus fusion constructs, Venus andX.laevis
Rps4x.S sequences were inserted into the BamHI-RcoRI sites of pCS2+. In these constructs, a CMV promoter drives the expression
of 50 UTR(Rps4x.S)-Venus-linker (Gly-Gly-Ser-Gly-Gly-Gly-Ser-Gly)-CDS (Rps4x.S, NM_001097003.1)-30 UTR(Rps4x.S). Because
frog 50 UTR sequences of Rps4x.S in public databases could be truncated, we used a sequence of actually transcribed mRNA in
frog embryos, which is obtained from a previously published RNA-seq data (GSM1948717) mapped to genome Xla.v91: 50-cgcg
ctctcttcctgccagagttcagcgcgcactctttatcccggcgggaccggaaggaggaggtcttttcc-30. To construct the plasmids for the rescue experiment
of the morpholino phenotype, we replaced the b-actin cDNA of the morpholino insensitive b-actin/mGFP dual promoter construct
(Wong et al., 2017) with 50 UTR-CDS-30 UTR of Rps4x.S in which silent mutations (ATGGCTCGCGGACCGAAGAAGC = > ATGGCA
CGGGGCCCCAAAAAAC) were introduced to avoid morpholino binding. In the ‘‘del-CUIC’’ rescue construct, both of the two motifs
(TCTCTTCC and TCTTTTCC) in the 50 UTR were removed.
Axon Culture and SILAC
We performed the axon cultures as described above for RNA-seq analysis. Then, we treated the eyes with lysine- and arginine-free
L15 (60%)medium for 1hr. After eye removal to eliminate the cell bodies, the axonswere cultured in L15 depletionmedium containing
‘‘heavy’’ amino acids (84 mg/ml [13C6,15N4] l-arginine, 146 mg/ml [13C6,15N2] l-lysine (Silantes, Germany) and Netrin-1 (600 ng/ml;
R&D systems) for 3hrs. Soma removal was confirmed by absence of nuclear DAPI staining. For the preparation of control eye sam-
ples, we cultured dissected eyes in L15 depletion medium containing ‘‘heavy’’ amino acids at room temperature for 48hrs. Lysis of
axons was performed using 500 mL Lysis buffer (9mM Tris-HCl pH 7.4, 270mM KCl, 9 mM MgCl2, 1% n-octylglycoside (Sigma-
Aldrich),100mg/ml cycloheximide (Sigma-Aldrich), 0.5mM DTT, EDTA-free protease inhibitor cocktail (Roche) and SUPERase In
RNase Inhibitor (Ambion)). Lysates were centrifuged at 16.000 g at 4C for 15 min and the supernatant was transferred to an ice-
cold 1.5ml tube. For the puromycin/RNaseA/T1 treated sample, axons were treated with 200 mM puromycin for 15min before lysis
and lysates were treated with 10 mg/ml RNase A (Ambion) and 250U RNase T1 (Ambion) for 15 min at 25C.
Polysome Fractionation
For density gradient fractionation, the lysate was layered on a sucrose gradient (10%–50%) and ultracentrifugation was performed
using a Beckman SW-40Ti rotor and Beckman Optima L-100 XP ultracentrifuge, with a speed of 35,000 rpm at 4C for 160min. Frac-
tionations and UV absorbance profiling were carried out using Density Gradient Fractionation System (Teledyne ISCO). For sucrose
cushioning, the lysate was layered on a 20% sucrose solution (20% sucrose, 10 mM Tris-HCl pH 7.4, 300 mM KCl,10 mM MgCl2),
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performed using a Beckman SW-55Ti rotor and Beckman Optima L-100 XP ultracentrifuge, with a speed of 41,000rpm at 4C for
120 min. Proteins were precipitated from each fraction using methanol-chloroform precipitation and pellets were resuspended in
1x NuPAGE LDS sample buffer and used for western blotting as described below. RNA from each fraction was isolated as described
below.
Quantitative PCR
RNA from fractionated samples or from the axonal compartment of themicrofluidic chambers were isolated using the RNeasymini kit
(QIAGEN) and reverse transcribed into cDNAusing randomhexamers and the SuperScript III First-strand synthesis kit (Thermo Fisher
Scientific). Triplicate reactions for qPCRwere prepared using this cDNA and theQuantitect SYBRGreen PCR kit (QIAGEN) according
tomanufacturer’s instructions. Plates were centrifuged shortly and run on a LightCycler 480machine (Roche) using the following PCR
conditions: denaturation step for 15 s at 94C; annealing step for 30 s at 60C; extension step for 30 s at 72C. The following primers
were used for qPCR: 18S rRNA 50-GTAACCCGCTGAACCCCGTT-30 and 50-CCATCCAATCGGTAGTAGCG-30.
50RACE and RT-PCR
We used 50 RACE System for Rapid Amplification of cDNA Ends, version 2.0 (Thermo Fisher scientific) and followed. For the cDNA
synthesis, we used the primer: 50-GGTCCACGAGCAAAGACACCAGTCAA-30. For the 1st PCR amplification, we used a reverse
primer: 50-GCAAAGACACCAGTCAACTTGTCCAACATC-30. For the 2nd PCR amplification, we used a reverse primer: 50-AACAC
GCTTCAAGTGCTTTTTCGGTCCA-30.
We purified the amplified product from gel after the electrophoresis by using Wizard SV Gel and PCR Clean-Up System (Promega)
and performed the direct sequence of the purified DNA using the primer: 50-GTGCTTTTTCGGTCCACGAGCAAAGAC-30. For the
amplification of pre-rRNA, the following primers were used: 18S-5end-F 50-GAGCGAGAGAGAAAGACGGA-30 and 18S-5end-R
50- TCTAGAGTCACCAAAGCGGC-30.
PCR amplifications were performed using Ex Taq HS (Takara).
Axonal Morpholino Delivery in vitro
Modified microfluidic chambers (Xona microfluidics, SOC150) were pre-coated with poly-L-lysine (10 mg/ml) and laminin (10 mg/ml).
Eyes dissected from stage 30-33 X. laevis embryos were plated in the open chamber of SOC150. RGC axons were grown in 60% L15
medium containing mg/ul penicillin streptomycin fungizone at room temperature for 48 hr. For the morpholino introduction, we pre-
pared two solutions: diluted transfection reagent (2 mL NeuroPORTER Transfection Reagent (Sigma-Aldrich) with 5.5 mL L15 (60%))
and morpholino solution (2.5 mL of 1mM morpholino oligonucleotide (mixture of 50-CTTTTTCGGTCCACGAGCCATTTTC-30 (against
Rps4x.L) and 50-TTCTTCGGTCCGCGAGCCATG-30 (against Rps4x.S) or 50-ACCTTTACGAACCCCATTTTGCTCT-30 (against Rpl5) or
a mixture of 50-TCTTGTTCTTGCCGACTGCCATC-30 (against Rps3a.S) and 50-GTTCTTGCCCACTGCCATCTTGC-30 (against
Rps3a.L) with 5 mL L15 (60%)). We mixed 7.5 mL morpholino solution with 7.5 mL diluted transfection reagent and incubated the
mixture at room temperature for 5 min. We added the 15 mL of mixture directly to 200 mL of the medium present in the axon chamber
and incubated it at room temperature for 18-24 hours.
Immunohistochemistry
Microfluidic chamber cultures were treated with 600ng/ml Netrin-1 (R&D systems) for 20 minutes and then fixed after detaching mi-
crofluidic chambers from the glass bottom dishes in 2% formaldehyde/7,5% sucrose in PBS for 20 min at 20C. The fixed cultures
were steamed for 10min in sodium citrate buffer for antigen retrieval in case of ribosomal protein staining. Subsequently, they were
permeabilized for 3-5 min in 0.1% Triton X-100 in PBS and blocked with 5% heat-inactivated goat serum in PBS for 45 min at 20C.
Primary antibodies were incubated overnight at 4C, followed by Alexa Fluor-conjugated secondary antibodies for 45 min at 20C in
the dark. Cultures were mounted in FluorSave (Calbiochem).
Antibodies were used at the following dilutions. Primary antibodies: rabbit anti-Rps4x (Proteintech, Cat#14799-1-AP; RRID:
AB_2238567, 1:200), 1:200 rabbit anti-Rpl17 (Proteintech, Cat#14121-1-AP; RRID: AB_2253985, 1:200), rabbit-anti-Rps3a (Protein-
tech, Cat#14123-1-AP; RRID: AB_2253921). Secondary antibodies: goat anti-rabbit Alexa Fluor 594 (Abcam, Cat#ab150080; RRID:
AB_2650602, 1:1000). Culture medium in the axonal compartment was replaced with 200 mL of culture medium containing 600ng/ml
Netrin-1 and 10mg/ml puromycin (Sigma). After 20min, the axonal compartment was washed once with fresh culture medium before
detaching the microfluidic chamber from the dish. The retinal culture was immediately fixed in 2% formaldehyde/7,5% sucrose in
PBS for 20 min at 20C, permeabilized for 3-5 min in 0.1% Triton X-100 in PBS, blocked with 5% heat-inactivated goat serum in
PBS for 30 min at 20C and then labeled with Alexa Fluor 647-conjugated mouse anti-puromycin antibody (Millipore,
Cat#MABE343-AF647, 1:250) overnight at 4C. Cultures were mounted in FluorSave (Calbiochem).
Transfilters from Boyden chambers were immunostained after eye removal using mouse-anti-neurofilament A (Developmental
Studies Hybridoma Bank, Cat#3A10; RRID: AB_531874) and DAPI, as previously described (Cagnetta et al., 2018).
For qIF or immunostaining on regular Xenopus retinal cultures (Figures 2D, 2E, 5F, S2D, and S2E), cultures were treated with or
without 50 mM cycloheximide (Sigma) and 600ng/ml Netrin-1 for 5 minutes before fixation in 2% formaldehyde/7,5% sucrose in
PBS for 20 min at 20C. For Rps12 qIF, 600ng/ml Netrin-1 was added for 30 minutes before fixation. The fixed cultures were
steamed for 10min in sodium citrate buffer for antigen retrieval in case of ribosomal protein and Npm1 staining. For Abce1 ande5 Cell Reports 29, 3605–3619.e1–e10, December 10, 2019
Gtpbp4 immunostaining, methanol fixation was used. The cultures were then permeabilized and blocked as described above and
stained with primary antibodies were incubated overnight at 4C, followed by Alexa Fluor-conjugated secondary antibodies for
45 min at 20C in the dark. Cultures were mounted in FluorSave (Calbiochem). The following antibodies were used: rabbit anti-
Rps14 (Abcam, Cat#ab174661; 1:200), rabbit anti-Rps4x (Proteintech, Cat#14799-1-AP; RRID: AB_2238567, 1:200), rabbit anti-
Rpl39 (Abcam, Cat#ab74740; RRID: AB_1524345, 1:200), rabbit anti-Rps12 (Proteintech, Cat#16490-1-AP; RRID: AB_2146233,
1:200), rabbit anti-Abce1 (Abcam, Cat#ab32270; RRID: AB_722514, 1:200), rabbit anti-Gtpbp4 (Abcam, Cat#ab92342; RRID:
AB_2049721, 1:200), mouse anti-Npm1 (Origene, Cat#BM5524; RRID: AB_1008764, 1:200), Secondary antibodies: goat anti-rabbit
Alexa Fluor 594 (Abcam, Cat#ab150080; RRID: AB_2650602, 1:1000), goat anti-mouse Alexa Fluor 568 (Abcam, Cat#ab150117;
RRID: AB_2688012, 1:1000).
Randomly selected non-collapsed growth cones were imaged at 60x on a Nikon Eclipse TE2000-U invertedmicroscope equipped
with an EMCCD camera. For Abce1, Gtpbp4 and Npm1 immunostaining, imaging was carried out at 100x on a Perkin Elmer Spinning
Disk UltraVIEW ERS, Olympus IX81 inverted microscope. Exposure time was kept constant and below gray-scale pixel saturation.
Blastomere Microinjection
Embryosweremicroinjected with Cy5-UTP at 100 mM in a total volume of 5nl (PerkinElmer) into both of the dorsal blastomeres at 4- or
8-cell stage (Wong et al., 2017). Embryos were first de-jellied in 2% Cysteine (Sigma-Aldrich) in 1x MBS (pH 8.0), washed 3 times in
0.1x MBS and aligned on a grid in 4% Ficoll (Sigma-Aldrich) in 0.1x MBS with 1X antibiotic-antimyotic (Thermo Fisher Scientific). In-
jections were performed using glass capillary needles (outer diameter: 1.0mm; inner diameter: 0.5mm; Harvard Apparatus) and a
pressurized microinjector (Picospritzer, General Valve).
FUNCAT-rRNA Proximity Ligation Assay
Xenopus retinal explants from stage 35-36 embryos were first cultured as described above in complete 60% L-15 medium (GIBCO,
Thermo Fisher Scientific) for 24 hours, whichwas then replacedwithmethionine-free L-15medium (GIBCO, Thermo Fisher Scientific)
for a further 12 hours. After 11 hours, 200mM anisomycin (Sigma-Aldrich) was added into the culture for the +anisomycin condition
and an equal concentration and volume of DMSO (Sigma-Aldrich) was added to all other conditions. After 1 hour, axons were severed
from the explants to exclude axonal transport of nascent peptides synthesized in the cell bodies, immediately followed by the addi-
tion of 1mM AHA (Thermo Fisher Scientific) and 600ng/ml Netrin-1 (R&D) in the +AHA +Netrin-1 and +anisomycin conditions, 1mM
AHA in the +AHA -Netrin condition, or an equal concentration and volume of DMSO (as in the AHA stock solution) and 600ng/ml Ne-
trin-1 in the -AHA condition. After 45minutes, 200mMpuromycin (Sigma-Aldrich) wasmixed into the AHA- and/or Netrin-1-containing
medium for a further 15 min incubation to release all synthesizing polypeptides from axonal ribosomes. After washing once with PBS
to remove unincorporated AHA, the cultures were fixed in 2% formaldehyde/7.5% sucrose in PBS for 20 min at 20C and permea-
bilized for 5 min in 0.1% Triton X-100 in PBS. The Click Chemistry reaction was performed according to the manufacturer’s protocol
(Click-iT Cell Reaction Buffer Kit, Thermo Fisher Scientific) starting with washing the fixed cultures with 2% BSA in PBS (w/v) and
incubating the culture for 30 min at 20C in freshly prepared Click-iT reaction cocktail containing the Click-iT cell reaction buffer,
the buffer additive, CuSO4 and 5mM biotin-alkyne (Thermo Fisher Scientific). The cultures were then washed once in 2% BSA in
PBS (w/v) and blockedwith 5%heat-inactivated goat serum in PBS for 30min at 20C. Amouse anti-ribosomal RNA (Y10B) antibody
(1:100, Abcam, Cat#ab171119) and a rabbit anti-biotin antibody (1:200, Cell Signaling, Cat#5597, RRID: AB_10828011) were incu-
bated overnight at 4C. The proximity ligation assay was carried out according to the manufacturer’s protocol (Duolink, Sigma-Al-
drich) with minor modifications. Dishes were washed twice for 5 minutes with 0.002% Triton X-100 in PBS and incubated with
anti-rabbit (+) and anti-mouse (-) PLA probes for 1 hour at 37C, with ligase for 30min at 37C andwith the polymerasemix with green
fluorescence for 100 min at 37C. The samples were subsequently mounted with mounting medium (Duolink, Sigma-Aldrich) and
imaged using an Olympus IX81 inverted microscope fitted with a PerkinElmer Spinning Disk UltraVIEW VoX using a 60x silicone
oil objective (1.4 N.A., Olympus), and an ORCA-Flash4.0 V2 CMOS camera (Hamamatsu). Volocity 6.3.0 software (PerkinElmer)
was used for acquisition. The number of discrete fluorescent puncta within a randomly chosen 50mm axon segment in each image
was counted using Volocity software.
Fluorescence Recovery After Photobleaching
Retinal cultures for FRAP assays were obtained from eyes of stage 33/34 embryos expressing one of the four Venus constructs (Fig-
ures 2F and S2F) or Venus-Rps4x / Venus-only for Cy5-UTP colocalization experiments (Figures 4D, 4E, and S4). These constructs
were introduced by eye-targeted electroporation at stage 26 as described in previous studies (Falk et al., 2007; Wong et al., 2017).
1mg/ml Venus construct (Figures 2F and S2F) or 1.5mg/ml of Venus-Rps4x (Venus only) with 100uM Cy5-UTP (Figures 4D, 4E, and S4)
were injected for the electroporation.
FRAP imagingwas performed on anOlympus IX81 invertedmicroscope equippedwith a PerkinElmer SpinningDisk UltraVIEWVoX
and a 60x (NA, 1.30) Olympus silicone oil immersion objective. Images were acquired with an ORCA-Flash4.0 V2 CMOS camera
(Hamamatsu) using Volocity software (PerkinElmer). Photobleaching was performed using an UltraVIEW PhotoKinesis device
(PerkinElmer). Photobleaching was performed at 85%–90% laser power (488 nm laser line) with 20–30 bleach cycles.
For the FRAP experiment imaging axons expressing Rps4x UTR-containing Venus constructs or the Venus-only construct indi-
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the culture. A randomly selected fluorescent growth cone of a severed axon then proceeded to the photobleaching step using 488 nm
laser line, immediately after pre-photobleaching fluorescent and phase contrast images were acquired. The photobleached area was
manually defined so that growth cones and > 50 mm of the axon shaft were bleached (thus reducing likelihood of fluorescence re-
covery resulting from Venus diffusion from unbleached areas of the axon shaft). In anisomycin-treated condition, 24h cultures
were incubated with 100mM anisomycin for 20 min before severing the axons. Time-lapse post-photobleaching images were
captured at 1 min intervals using a 488 nm laser line at 20% laser power, together with phase contrast images for the corresponding
time point. Exposure time was adjusted to avoid pixel saturation.
For the FRAP experiment imaging axons expressing Cy5-UTP and Venus-Rps4x fusion construct or Venus-only construct shown
in Figures 4D and S4, axons of the 24h retinal cultures were severed from the eye and 600ng/ml Netrin-1 was added into the culture. A
30 s pre-photobleaching movie at maximum speed of a randomly selected Cy5- and Venus-positive 50 mmaxon segment was taken,
followed by photobleaching of the Venus fluorescence using a 488 nm laser line. 30 s post-photobleaching fluorescent and phase
contrast movies at maximum speed were acquired at 0 min, 5 min and 10 min after the completion of photobleaching. Exposure
time was adjusted to avoid pixel saturation.
Single Molecule Translation Imaging
Single molecule translation imaging was done as previously described(Ströhl et al., 2017; Tatavarty et al., 2012). Embryos at
stage 26 were electroporated with plasmids expressing Rps4x UTR-containing Venus constructs or the Venus-only and left in
0.1X MBS to continue to develop. Venus-expressing eyes from electroporated embryos at stage 34 were dissected and cultured.
After 24 hours, a non-collapsed fluorescent growth cone was randomly selected and, prior to the bleaching step, imaged with
low irradiance (< 2W/cm2) in both fluorescence and bright field mode to generate an outline image. The growth cone was then photo-
bleached for 10-30 s with an irradiance of 1.5 kW/cm2 to eliminate the fluorescence. A reduced laser intensity of 0.3 kW/cm2 was
used to ensure survival of the axons while simultaneously bleaching newly synthesized Venus proteins. The flash-like recovery of
Venus fluorescence recorded with an exposure time of 200 ms for 180 s. After that another bright field image was taken to check
for survival. Retracted growth cones were excluded from analysis. In Netrin-1-stimulated conditions, 600ng/ml of Netrin-1 was
bath applied immediately before the photobleaching step. All imaging steps were performed under epifluorescence illumination.
An EM gain of 200 was used on the EMCCD camera to ensure single molecule sensitivity. The field of illumination was twice the
size of the imaged field of view to bleach diffusing or transported fluorescent proteins from outside the growth cone before entering
the field of view. Imaging was performed on a custom-made inverted single-molecule fluorescence microscope built around a com-
mercial microscope frame (Olympus IX73). The illumination laser wavelength was at 488nm (Coherent Sapphire) for excitation of the
YFP derivate Venus in combination with a 525/645-emission filter (Semrock) and a dichroic beam splitter (Chroma ZT405/488/561/
640rpc). The laser beam was circularly polarized to excite fluorescent proteins homogeneously regardless of their orientation. The
microscope was equipped with an EM-CCD camera (Andor iXon Ultra 897) with effective pixel size on the sample of 118 nm. A
100x NA = 1.49 oil immersion TIRF objective (Olympus) was used.
In Vivo Knockdown and Imaging
Targeted eye and tectal electroporations were performed as previously described (Falk et al., 2007; Wong et al., 2017). Stage 28 em-
bryos were anesthetized in 0.4mg/ml MS222 in 1X MBS. The retinal primordium was injected with electroporation mixture, followed
by electric pulses of 50ms duration at 1000ms intervals, delivered at 18V (please refer to the list below for themixture and the number
of electric pulses delivered for each experiment). The embryos were recovered and raised in 0.1X MBS until the desired embryonic
stage for experiment.
1) Mature axon visualization (Figures 7B–7D and S7): 1mg/ml of pCS2+mGFP (or 1mg/ml of pCS2+mGFP/MO resistant Rps4x
rescue dual promoter construct cDNA for rescue experiments), 0.5mM control/Rps4x MO; 1 pulse.
2) Axon branching dynamics (Figures 7E–7G and S7): 1mg/ml of pCS2+mGFP or 1mg/ml of pCS2+mRFP, 0.5mM control/Rps4x
MO; 4 pulses.
For tectal electroporation (Figures 7 and S7), the lateral surface of the hemisphere of the brain contralateral to the eye labeled with
mRFP (electroporated at Stage 28 as described above) was exposed by careful removal of overlying eye and epidermis. 8X 18V elec-
tric pulses of 50ms duration at 1000ms intervals were delivered immediately after the 1mM control/Rps4x MO was locally ejected at
the vicinity of the target area. The procedure was repeated once to ensure efficient delivery of the MO (Wong et al., 2017). Embryos
were lightly anaesthetized with 0.4mg/ml MS222 in 1xMBS. The lateral surface of the brain contralateral to the electroporated eye
was exposed by carefully removing the overlying epidermis and the contralateral eye. The electroporated eyes were also surgically
removed to prevent somal contribution of proteins in Figures 7F and S7. Embryos were mounted in an oxygenated chamber created
with Permanox slides (Sigma-Aldrich) and Gene Frame (ThermoFisher) and bathed in 1xMBS with 0.1mg/ml MS222, for visualization
with fluorescence microscopy. Imaging was performed using 40X (NA 1.25) or 60X UPLSAPO objectives (NA 1.3) with a PerkinElmer
Spinning Disk UltraVIEW ERS, Olympus IX81 inverted spinning disk confocal microscope. Z stack intervals of 1-2mmwere employed
for acquiring images with Volocity (PerkinElmer).e7 Cell Reports 29, 3605–3619.e1–e10, December 10, 2019
Western Blotting
Proteins were resolved by SDS-PAGE on NuPage 4%–12% Bis-Tris gels (Invitrogen) and transferred to a nitrocellulose membrane
(Bio-Rad). The blots were blocked in blocking buffer (5%milk in TBS-T) and then incubated with primary antibodies in blocking buffer
overnight at 4C. After 3washes (5minutes each) with TBS-T, the blots were incubatedwith HRP-conjugated secondary antibodies in
blocking buffer for 1 hour at RT, washed again for 3 times (5 minutes each) in TBS-T and developed using ECL-based detection
(Pierce ECL plus, Thermo Scientific). The following primary antibodies were used for western blot analysis: mouse anti-Rpl19
(Abcam, Cat#ab58328; RRID: AB_945305, 1:1000), mouse anti-Rps23 (Abcam, Cat#ab57644; RRID: AB_945314, 1:1000), rabbit
anti-Rps4X (Proteintech, Cat#14799-1-AP; RRID: AB_2238567, 1:1000), rabbit b-catenin (Sigma-Aldrich, Cat#C2206; RRID:
AB_476831, 1:8000) and rabbit anti-b-actin (Abcam, Cat#ab8227; RRID: AB_2305186).
Mass Spectrometry
1D gel bands were transferred into a 96-well PCR plate. The bands were cut into 1mm2 pieces, de-stained, reduced (DTT) and alky-
lated (iodoacetamide) and subjected to enzymatic digestion with chymotrypsin overnight at 37C. After digestion, the supernatant
was pipetted into a sample vial and loaded onto an autosampler for automated LC-MS/MS analysis. LC-MS/MS experiments
were performed using a Dionex Ultimate 3000 RSLC nanoUPLC (Thermo Fisher Scientific Inc., Waltham, MA, USA) system and a
Q Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific Inc, Waltham, MA, USA). Separation of peptides was performed
by reverse-phase chromatography at a flow rate of 300nL/min and a Thermo Scientific reverse-phase nano Easy-spray column
(Thermo Scientific PepMap C18, 2 mm particle size, 100A pore size, 75 mm i.d. x 50cm length). Peptides were loaded onto a pre-col-
umn (Thermo Scientific PepMap 100 C18, 5 mm particle size, 100A pore size, 300 mm i.d. x 5mm length) from the Ultimate 3000 au-
tosampler with 0.1% formic acid for 3 minutes at a flow rate of 10 mL/min. After this period, the column valve was switched to allow
elution of peptides from the pre-column onto the analytical column. Solvent A was water + 0.1% formic acid and solvent B was 80%
acetonitrile, 20%water + 0.1% formic acid. The linear gradient employed was 2%–40%B in 30 minutes. The LC eluant was sprayed
into the mass spectrometer by means of an Easy-Spray source (Thermo Fisher Scientific Inc.). All m/z values of eluting ions were
measured in anOrbitrapmass analyzer, set at a resolution of 70000 andwas scanned betweenm/z 380-1500. Data-dependent scans
(Top 20) were employed to automatically isolate and generate fragment ions by higher energy collisional dissociation (HCD,
NCE:25%) in the HCD collision cell and measurement of the resulting fragment ions was performed in the Orbitrap analyzer, set
at a resolution of 17500. Singly charged ions and ions with unassigned charge states were excluded from being selected for MS/
MS and a dynamic exclusion window of 20 s was employed. For the label-free quantification of proteins, peptide identification
and relative quantification was carried out in Proteome Discoverer version 2.3. A standard label free quantification workflow was uti-
lized with the Mascot search algorithm, against a Xenopus laevis proteins downloaded from Xenbase. The search parameters
included: trypsin as the proteolytic enzyme, with maximum of two missed cleavages; variable oxidation modification of methionine,
and deamidation of asparagine and glutamine; fixed carbamidomethylation modification of cysteine; precursor and fragment mass
tolerances of 20 ppm and 0.1 Da respectively. The false discovery rate (FDR) was set at < 1% with two peptide matches to proteins
considered as reliable. For the analysis of SILAC labeled proteins, we used Maxquant in addition to Proteome Discoverer since it is
the most commonly used software for SILAC analysis. Raw data were processed using Maxquant (version 1.6.1.0) (Cox and Mann,
2008) with default settings. MS/MS spectra were searched against the X. laevis protein sequences from Xenbase (xlaevisProtein.
fasta). Enzyme specificity was set to trypsin/P, allowing a maximum of two missed cleavages. The minimal peptide length allowed
was set to seven amino acids. Global false discovery rates for peptide and protein identification were set to 1%. Thematch-between
runs and re-quantify options were enabled. To avoid false positives, we analyzed only those RPs where more than two labeled pep-
tides were detected by the software or if the MS spectrum of the detected labeled peptides showed clear peaks at the expected m/z
value.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics
The n number for each experiment, details of statistical analysis and software are described in the figure legends or main text. Sta-
tistical analyses used in this study include one-way ANOVA, Welch’s t test, Mann-Whitney U test, Kolmogorov–Smirnov test and
Fisher’s exact Test. Statistical significance is defined as, n.s., not significant, *p < 0.05, **p < 0.01, ***p < 0.001. Statistical analysis
was performed using R version 3.2.2 or Prism (GraphPad).
Bioinformatics Analysis
We analyzed the developmental change of level of all mRNAs translated in the mouse RGC axons in dataset (GSE79352). The
sequence reads were mapped to the mouse genome (mm10) using TopHat 2 version 2.0.12 with default settings, except for the
‘‘–read- realign- edit-dist 0’’ option. Transcript assembly and estimation of FPKM (Fragments Per Kilobase of transcript per Million
fragments sequenced) values were performed using Cufflinks version 2.2.1. For RNA-seq analysis of frog RGC axons, the sequence
reads were mapped to the X. laevis v9.2 genome (Xenbase) using HISAT2 2.1.0 with default settings. Transcript assembly and esti-
mation of FPKM (Fragments Per Kilobase of transcript per Million fragments sequenced) values were performed using Cufflinks
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of the pSILAC-SP3 results, we extracted all proteins that show a significant change (FDR < 0.01) by stimulation (5min or 30min) of
Netrin-1. We performed a GO enrichment analysis using DAVID 6.8 with default settings for BP-direct, MF-direct and CC-direct cat-
egories and used all detected proteins as the background of the enrichment calculation. For the ribosome structure analysis, we used
the PyMOL function InterfaceResidues (https://pymolwiki.org/index.php/Main_Page) to know the interface residues of RPs with
rRNAs. We analyzed the structure of human 80S ribosome (6ek0) published previously (Natchiar et al., 2017). For the small ribosomal
subunit proteins, we analyzed interface residues between RPs and 18S rRNA. For the large ribosomal subunit proteins, we analyzed
the interface residues of RPs with 5S, 5.8S and 28S rRNAs.
Motif Analysis
All sequences of mouse cDNAs were retrieved from BioMart at Ensembl (GRCm38, ensemble Genes 91).De novomotif analysis was
performed using HOMER version 3.0 with custom FASTA files containing all 50 UTR sequences of mouse RP-coding cDNAs. For the
analysis of CUIC-containing genes, we selected all genes whosemRNA contains the 8-mer nucleotides (T/C)(T/C)(T/C)(T/C)TT(T/C)C
located less than 100nt upstream of the initiation codon. The secondary structure analysis of UTRs was performed using performed
using RNAfold in the ViennaRNA package version 2.4.3 with default settings. The conservation among species of all CUIC-containing
RP mRNAs was calculated from phastCons60way.UCSC.mm10. For the analysis of proteins binding the CUIC region, we used Hu-
man RBP binding sites data downloaded from the POSTAR2 database (Zhu et al., 2019). To visualize the binding sites of EIF com-
ponents, we created custom tracks on the UCSC genome browser.
Quantification of Immunofluorescence
For quantitation of fluorescence intensity, the growth cone outline was traced on the phase contrast image using Volocity version
6.0.1 (PerkinElmer), then superimposed on the fluorescent image. The software calculated the fluorescent intensity within the growth
cone, giving a measurement of pixel intensity per unit area. The growth cone outline was then placed in an adjacent area clear of
cellular material to record the background fluorescent intensity. This reading was subtracted from the growth cone reading, yielding
the background-corrected intensity.
FRAP analysis
Quantification of fluorescence intensity was performed using Volocity software (PerkinElmer). At each time point, the outline of the
growth cone was traced using phase contrast images. Mean gray values from the 488-channel were subsequently calculated as
mean pixel intensity per unit area within the specified region of interest (ROI). This ROI was then placed in an adjacent area clear
of cellular material to record the background fluorescent intensity. This reading was subtracted from the growth cone reading,
yielding the background-corrected intensity. Unhealthy axons exhibiting signs of photo-toxicity after FRAP (characterized by bleb-
bing, growth cone collapse and/or retraction) were excluded from analysis. In addition, only growth cones of axons extending more
than 100 mm from the eye explant were quantified to reduce effects of somal diffusion. Relative fluorescent recovery (R) at each time
point was calculated by the formula: Rx = (Ix – Ipost) / (Ipre – Ipost). Where, Ix = normalized fluorescent intensity of the growth cone
ROI at time point ‘x’, Ipre = normalized fluorescent intensity before photobleaching and Ipost = normalized fluorescent intensity
immediately after photobleaching (t = 0mins). Significance was tested using a two-way ANOVA. Colocalization analysis between
Cy5-RNA granules and Venus-Rps4x (N = 8 axons) or Venus (N = 12 axons) in Figure 4E was performed on the first image of a
30 s movie taken 10min post-photobleaching. In each image, a 5um axon segment containing Cy5-RNA granules and recovered
Venus-Rps4x or Venus signal was chosen and the Pearson’s correlation coefficient between Cy5 and Venus channels within the
selected area was measured by Volocity software.
Single Molecule Translation Imaging Analysis
Translation event counting was performed by manual counting supplemented with the previously reported software-assisted auto-
mated event detection(Ströhl et al., 2017), where localizations of individual protein translation events were retrieved using maximum
likelihood estimation with a Gaussian model fit via the software package rapidSTORM. A threshold of6700 ADC, corresponding to
500 photons per localization, was applied to filter out noise and non-Venus blinking events. This threshold was found by manual
selection of Venus flashes and determination of the ‘‘average’’ photon budget of a single emitting Venus molecule. The tracking op-
tion of rapidSTORM was used to recombine photons emanating from the same Venus protein over multiple frames. All events in a
small area around the growth cones were included for analysis due to the high mobility of filopodia. Results are normalized to the
growth cone area, thus given as event/s/mm2.
Branching Analysis
A filopodiumwas defined as a protrusionwith length < 5 mmwhile a branchwas defined as a protrusionwith length > 5 mm (Drinjakovic
et al., 2010; Hörnberg et al., 2013; Kalous et al., 2014; Wong et al., 2017). Data were analyzed in PRISM 7 (GraphPad). ‘n’ represents
the number of axons. *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.05, ##p < 0.01, ###p < 0.001. Details of statistic results such as
p values, degree of freedom, and t/F values are presented in the figure legends. For axon arbor analysis, 3D projection of axon arbors
acquired at 40X were semi-automatically traced through the z axis using the Simple Neurite Tracer plugin (Longair et al., 2011) in Fiji.
The resulting traces were then analyzed for the number and the length of axon branches as well as the Axon Complexity Index (ACI)e9 Cell Reports 29, 3605–3619.e1–e10, December 10, 2019
(Marshak et al., 2007). These measured parameters were compared using one-way ANOVA with the Two-stage step-up method of
Benjamini, Krieger and Yekutieli multiple comparisons test. Cumulative distribution curves of total branch number represent least-
squares fits to a Gaussian function and were compared using Extra sum-of-squares F test. The proportions of simple (ACI < 1.4)
and complex (ACI R 1.4) arbors in different groups were compared using Fisher’s exact test (Drinjakovic et al., 2010). For analysis
of branching dynamics, the numbers of protrusions added and removedwere counted on the terminal 50 mmofmGFP/mRFP-labeled
RGC axons for 10min (imaged at an interval of 30 s) (Wong et al., 2017). The addition and removal of protrusions were then compared
statistically. A paired t test was used for intragroup comparison and unpaired t test was used for intergroup comparisons.
Western Blot Analysis
Developed films from western blot detection were scanned and imported into FIJI. The color was inverted and the background cor-
rected signals for Rps4x and b-catenin were measured. Measured Rps4x levels were then normalized to b-catenin to obtain a ratio-
metric readout. A paired t test was used to assess differences in Rps4X protein levels between control MO and Rps4X MO samples
(n = 3 independent experiments).
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the mass spectrometry proteomics data reported in this paper are PRIDE: PXD011032 and PRIDE:
PXD015574. The accession number for the RNA-seq data reported in this paper is GEO: GSE135502.Cell Reports 29, 3605–3619.e1–e10, December 10, 2019 e10
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A B NF-A 3A10 DAPINeurofilament DAPI 
Figure S1, Related to Figure 1. (A) Diagram showing the physical separation of RGC axons f om cell bodies in a 
Boyden chamber device. (B) Immunostaining images of pure axons, obtained with a Boyden chamber, with anti 
neurofilament-associated antigen antibody (3A10) and DAPI after the removal of cell bodies. Scale bar = 50µm. (C) A 
bar/line graph showing the result of de novo motif discovery for the 5’ UTR of mouse RPs using HOMER. Grey bars 
show the percentage of motif-containing targets and the blue line represents the p-values. (D) Kernel density estimation 
of lengths between 5’ end and the CUIC motif, and between the CUIC motif and the initiation codon (ATG). (E) 
Enrichment plot of GO terms (GOTERM_BP_5 and GOTERM_CC_5) of all CUIC-containing mouse genes, analyzed 
using DAVID. (F) A graph showing the average and 95% CI of the relative abundance (log2(FPKM)) of all genes with 
or without the CUIC motif in mouse RGC axons of 4 different developmental stages of mouse RGC axons 
(***p<0.001, Kolmogorov–Smirnov test, compared to “without CUIC”). (G) Examples of RNA secondary structures of 
CUIC containing 5’ UTRs of several RPs. (H) Average interspecies conservation scores using PhastCons 
(mm10.60way.PhastCons) around the CUIC motif in mouse RP-coding mRNAs. 
A 
Netrin-1 increase log2FC Netrin-1 decrease log2FC
rps4x 4.26 rab10 -2.91
lsm4 4.15 psma4 -2.67
kazald1 3.9 LOC100137679 -2.52
cd81 3.375 MGC81848 -2.515
nrn1 2.88 ero1l -2.27
atp6v1g1 2.645 park7 -2.1
ldhb 2.1 atp6v1h -1.88
bola2 2.08 ppa2 -1.88
f7 1.97 eif3e -1.75
fabp7 1.915 aldh16a1 -1.73
rpl18 1.86 ndufa8 -1.69
rps16 1.81 lap3 -1.655
nme2 1.76 mvp -1.65
slc2a1 1.76 nell2 -1.525
RG 1.665 rab6b -1.505
klc1 1.66 epb41l3 -1.5
ctnnb1 1.64 ddb1 -1.49
atp1b3 1.59 hspe1 -1.4
vdac2 1.53 dynll1 -1.29
rtn3 1.52 pmp2 -1.29
MGC82602 1.52 eef2.1 -1.275
hnrnph3 1.51 napsa -1.265
canx 1.49 cetp -1.26
cltb 1.44 srsf2 -1.26
p44s10 1.385 vwa5a.2 -1.255
pin1 1.38 nudc -1.225
rps14 1.33 ldlr -1.17
apoc1 1.305 mfge8 -1.17
ubqln4 1.3 g3bp1 -1.12
hnrnph1 1.26 skp1 -1.11
hnrnpa0 1.24 prdx2 -1.035
ppp2r2a 1.24 cdc42 -0.97
plscr2 1.23 pdcd5 -0.97
rpl11 1.19 loc100498624 -0.97
rab14 1.185 anp32e -0.965
pdia4 1.175 cirbp -0.965
ppp3r1 1.165 col2a1 -0.905
rpl5 1.165 LOC445859 -0.875
ran 1.12 tuba3c -0.865
psmd4 1.075 olfm1 -0.815
psma3 1.07 thbs1 -0.815
pdhb 1.06 dfna20 -0.81
lta4h 1.05 lmnb1 -0.8
glul 1.05 actb -0.74
tagln2 1.05 st3gal6 -0.735
calr 1.025 tubb4a -0.705
atp6v1b2 0.97 hspa9 -0.695
acad9 0.955 gpm6b -0.675
anp32c 0.91 gyg -0.665
pcolce 0.905 rbp4l -0.61
ndrg2 0.895 lgals3 -0.61
dcn 0.885 mdh2 -0.535
stip1 0.85 rtn4 -0.49
LOC398563 0.825 col18a1 -0.44
naca.2 0.805 pafah1b1 -0.43
psmb6 0.795 psap -0.415
gstt1 0.775 rbp4 -0.4
atp5a1 0.735 pcca -0.335
anxa5 0.735 cct5 -0.33
calu 0.72 nasp -0.325
cisd1 0.71 eif5a -0.325
metrnl 0.69 rps18 -0.315
























































































































































Figure S2, Related to Figure 2. (A) Mouse 5’ UTR example sequences for several RP mRNAs containing CUIC (red) 
and 5’TOP (blue) motifs separately. (B) Genome browser view of coverage of RNA-seq reads on the 5’end of two RP-
coding mRNAs showing 5’ ends truncated close to the CUIC-motif in axons.  (C) List of proteins whose translation in 
axons are significantly changed by Netrin-1 stimulation. RPs are highlighted in boxes. (D-E) Representative images (D) 
and qIF plots (E) for Rps12/eS12 and Rpl39/eL39 in axonal growth cones **with and without Netrin-1 following 30 
min and 5 min stimulation, respectively (bars = average with 95% CI, Mann–Whitney U test, *** p 0.001). Scale bar = 
5µm. (F) Relative fluorescence recovery of indicated Venus reporter constructs after photobleaching (error bar = SEM) 
in RGC axons with anisomycin and Netrin-1 treatment. 
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Figure S3, Related to Figure 3. (A-B) UV absorbance (A254) profile of sucrose density gradients (A) and Western 
blot analysis using antibodies against Rps23/uS12, Rpl19/eL19 and b-actin (B) for each fraction of the whole brain 
sample. (C) qRT-PCR detection of 18S rRNA in each fraction of the axon and whole brain sample after the sucrose 
density gradient fractionation. (D) Heat map showing ratio of RP abundance (free / mono-polysome) for the axon and 
whole brain sample (average of two biological replicates). (E) Heatmap with the ranking of abundance (LFQ 
abundance scores) of RPs detected in the ribosome free fraction of the axon sample, and their Interface Index scores 
(more blue = higher, more red = lower). High Interface-Indices (> 0.6, framed) were significantly depleted from the 
group of RPs with high abundance (LFQ abundance score > 1) in the axonal ribosome-free fraction (2.6 fold 





































































































































































































































Figure S4, Related to Figure 4. Images and kymographs (30 sec) obtained from the movies of same axon in Figure 
4D to show co-localization and co-movement between Cy5-UTP (magenta) and UTR-Rps4x/eS4-Venus fusion or 




























































































































































































3. eukaryotic initiation factor 4G binding
4. protein self-association
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Figure S5, Related to Figure 5. (A) Gene network analysis of proteins detected in the axonal ribosome sample by 
MaxQuant. (B) Scatter plot showing abundance (log2 (intensity)) of labeled and unlabeled RP peptides detected in any 
of the biological replicates by MaxQuant. (C) UV absorbance (A254) profile and immunoblot detection of Rpl19/eL19 
in each fraction of samples with and without RNase A/T1 treatment. (D) Left panel shows the average number of 
peptides (RPs: orange, other proteins: green) detected in the puromycin/RnaseA/T1-treated and untreated axonal 
ribosome sample. Right panel shows the comparison of the intensity of a peptide from Rps4x/eS4. (E) GO terms 
enriched in the group of which the LFQ intensities are significantly decreased in the brain ribosome sample by RNaseA/
T1 treatment. (F) Heatmap showing the protein abundance (LFQ intensity) in the brain ribosome samples with or 
without the RNaseA/T1 treatment. (G) Venn diagram showing the overlapping of nucleolar/ribosomal assembly factors 
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32 A.  Growth cone of mouse callosal axons 
(Poulopoulos et al., 2019)  
B.  Axon of rat cortical neurons  
    (Chuang et al., 2018)  
 
C.  Axon of Xenopus RGCs 






















































































Figure S6, Related to Figure 6. (A) Western blots of protein samples isolated from the somal compartment from 
Control MO or Rps4x/eS4 MO treated samples. (B) Bar graph showing Western blot quantification of Rps4x/eS4 
protein levels, normalized to -Catenin protein levels. n = 3, error bars = SEM, Welch t-test (not significant). (C-
D) Images (C) and plots (D) of average, 95% CI and distribution of normalized levels of puromycin incorporation 
in the axons treated with control morpholinos (Cont.) or with morpholinos against Rpl5/uL18, with Welch t-test 
(not significant).
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Figure S7, Related to Figure 7. (A) The cumulative distribution of total branch number (Extra sum-of-squares F test). 
(B) Formulation of axon complexity index (ACI). (C) A bar graph showing the number of branches in Control, Rps4x/
eS4 morphants and Rps4x/eS4 morphants with different rescue constructs (primary: F4,146=5.3, p=0.0005; secondary: 
F4,146=12.8, p<0.0001; tertiary: F4,146=7.6, p<0.0001; total: F4,146=11.14,p<0.0001). (D-F)Time-lapse images of 
axonal branching in the tectum after eye electroporation (Whole cell KD, upper: stage 28) (D) and tectum 
electroporation at stages 41-43 (Axonal KD) (E) and at stage 35/36-37/38 (Tectum KD) (F). Scale bar = 20µm. (G) A 








 translation maintains 
the ribosome function 
Transport of RP-coding mRNAs 














































0’ 2’ 4’ 6’ 8’ 10’ 0’5’10’
C
o
n
tr
o
l M
O
R
p
s4
X
 M
O
C
o
n
tr
o
l M
O
R
p
s4
X
 M
O
